AzTrials
AzTrials

Medication Errors and Other Product Use Errors and IssuesNCT05885347

Innovative Teaching Solutions to Improve the Outcomes of Home Caregivers

A study testing 360 videos, VR and AR in people with Medication Errors and Other Product Use Errors and Issues, run by Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background. Population ageing is leading to an increase in the number of multi-pathological and polymedicated patients. These patients are at increased risk of suffering adverse events due to medication errors (ME), especially if Barthel≤55. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
360 videos, VR and AR
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
227 participants
Where
1 siteSpain
Study dates
1 Feb 2023to 7 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Caregivers currently

Who cannot join

  • Be familiar with disruptive technologies or suffer from vertigo

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Fundación Fisabio

    Sant Joan d'Alacant, Alicante, 03310

Other trials in Spain

About this study

Background. Population ageing is leading to an increase in the number of multi-pathological and polymedicated patients. These patients are at increased risk of suffering adverse events due to medication errors (ME), especially if Barthel≤55. The management of their medication places an added burden of stress on those who assume responsibility for their care. This task, due to the existing gender gap, falls more often on women.

Objective. To promote the safe use of medication in the home by those who assume the role of caregivers of these patients.

Read the detailed description

General objective. The main objective is to investigate whether the provision of care at home by caregivers of of people with multi-pathology and polypharmacy by formal/informal caregivers trained in VR/AR is more efficient formal/informal caregivers trained through VR/AR is more efficient than traditional training.

Secondary objectives are to provide competencies (knowledge, skills and attitudes) that contribute to reducing attitudes) that contribute to reducing caregiver care and medication errors by helping caregivers caregivers, helping beneficiaries to stay at home for as long as possible; and to determine the extent to which and to determine the extent to which AI allows us to continuously update VR training material.

VR training material. This project is in line with the WHO SDG 3. "Ensure healthy lives and promote well-being for all at all ages". It also responds to the WHO Medicines Without Harm challenge. At the national level, this study study reinforces those policies that aim to strengthen the new care economy and reduce the gender equality reduce the gender equality gap (Component 22, 16 June 2021). Specific objectives

  1. To create innovative materials to increase the effectiveness of training for formal and informal caregivers through informal and formal caregivers through VR/AR (fully immersive 3D videos).
  2. To determine the effectiveness and cost-effectiveness of VR/AR training in caregiving by caregivers.
  3. To determine the effectiveness and cost-effectiveness of VR/AR training in the provision of care by formal and informal caregivers and compare it with the outcomes of training using traditional procedures. outcomes of training using traditional procedures. 3. To analyse the ability of VR/AR to reduce errors in the provision of home-based care and medication by formal and informal caregivers and to compare it with the results of training using traditional procedures.
  4. To analyse the ability of RL/RH to reduce errors in the provision of care and medication in the home by formal and informal caregivers.
  5. To determine the usefulness of VR/RA in increasing caregivers' self-confidence, considering gender-related factors. 5. Determine the feasibility of combining the analysis of data captured during home care using AI (Deep home care using AI (Deep Learning) and the latest technological developments in VR/AR for smartphones in VR/AR for smartphones - virtual mapping (Arcore 1.24) and AR interaction (LifeAR) - to generate fully immersive generate fully immersive environments for caregiver training. METHODOLOGY Feasibility study of VR/AR/AR/IA applications in the context of caregiver training in three phases
  6. qualitative (to collect key information for the development of immersive environments for the key information to develop immersive environments for VR/AR-based interventions), (2) qualitative (to collect key VR/AR-based interventions), (2) experimental (to test the effectiveness of the intervention targeting caregivers (informal and formal), (3) qualitative (to test the effectiveness of the caregivers (informal and formal) to provide safe home-based care, including cost-effectiveness analysis, (3) experimental (to test effectiveness of cost-effectiveness analysis, (3) prototype development to capture and analyse performance of home-based care to
  7. development of prototypes to capture and analyse home-based care performance to promote improvements in training programmes through VR/AR. training programmes through VR/AR.
Being tested
360 videos, VR, AR, Control group

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 360 videosOther

    Caregivers will receive 2h session of 360 videos about caring and medication errors. Then Caregivers will be recorded performed the task worked in 360 videos instantly after the education and after 6 months.

  • VROther

    Caregivers will receive 2h session of VR about caring and medication errors. Then Caregivers will be recorded performed the task worked inVR instantly after the education and after 6 months.

  • AROther

    Caregivers will receive 2h session of AR videos about caring and medication errors. Then Caregivers will be recorded performed the task worked in AR videos instantly after the education and after 6 months.

  • Control groupOther

    Caregivers will follow the routine and then will be recorded performing their labour as a caregiver after 6 months.

Study groups in NCT05885347
Study groupRoleWhat they receive
Control groupPlacebo comparatorThis caregivers group will not receive any intervention different to the routinely practice.
Receives: Other: Control group
Video InterventionExperimentalCaregivers will be taught by a video intervention about how to develop their home tasks during an hour.
Receives: Other: 360 videos
Virtual realityExperimentalCaregivers will be taught by a VR intervention during 20minutes about how to develop their home tasks.
Receives: Other: VR
Augmented realityExperimentalCaregivers will be taught by a AR intervention during 20minutes about how to develop their home tasks.
Receives: Other: AR

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in errors by caregivers at home

    Caregivers will be recorded in the hospital performing their task in a simulation. All errors performed doing that situation will be counted by professionals who will reproduce that videos.

    Measured: 6 months

Secondary outcomes (1)
  1. Chronic Patient Experience Evaluation Instrument-IEXPAC

    Questionnaire regarding the experience of the patient care in a chronic situation, with 16 statements, that should be read in the order in which they appear and choose the option that best reflects the opinion. There are no right or wrong answers, it is own personal experience that matters. All statements refer to the last 6 months.

    Measured: 6 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2023
  2. Study start1 Feb 2023
  3. Primary completion28 Feb 2023
  4. Study completion7 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
227 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05885347
Sponsor's protocol ID
PI00868
Status last verified
Apr 2026
First submitted
31 Mar 2023
Last updated
4 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing 360 videos, VR and AR in people with Medication Errors and Other Product Use Errors and Issues, run by Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in errors by caregivers at home (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in